Healthcare Company Demonstrates Promising Clinical Results For Cancer Treatment
CEL-SCI's Phase 3 Population Analysis for Confirmatory Registration Study in Head & Neck Cancer Demonstrates Well-Balanced Patient Population and Confidence in Clinical Results.
Disclaimer: The following article presents information based on the Phase 3 study of Multikine in head and neck cancer treatment as reported by CEL-SCI Corporation. This content is intended for informational purposes only and should not be construed as medical advice or an endorsement of any specific treatment.
Real-time informati…